latanoprostene bunod 0.24 MG/ML Ophthalmic Solution

RxCUI
1988394
RxNorm name
latanoprostene bunod 0.24 MG/ML Ophthalmic Solution
Display name
latanoprostene bunod 0.24 MG/ML Ophthalmic Solution
Full name
latanoprostene bunod 0.24 MG/ML Ophthalmic Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Latanoprostene Bunod Ophthalmic Solution, 0.024%LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024%Gland Pharma Limited1beedfbd-5e2b-4ab1-ab8e-8320e69af1ea2025-05-02Warnings, Adverse reactionsExact identifier
rxcui: 1988394
VyzultaLATANOPROSTENE BUNODBausch & Lomb Incorporated60ce7900-a677-4fc2-88d0-1603baa9dbd42024-02-27Warnings, Adverse reactionsExact identifier
rxcui: 1988394

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
60ce7900-a677-4fc2-88d0-1603baa9dbd4latanoprostene bunod 0.024 % Ophthalmic Solution [PSN] · latanoprostene bunod 0.24 MG/ML Ophthalmic Solution [SCD] · latanoprostene bunod 0.024 % Ophthalmic Solution [SY]37These highlights do not include all the information needed to use VYZULTA safely and effectively. See full prescribing information for VYZULTA. VYZULTA ® (latanoprostene bunod ophthalmic solution) 0.024%, for topical ophthalmic use Initial U.S. Approval: 201720240227
1beedfbd-5e2b-4ab1-ab8e-8320e69af1ealatanoprostene bunod 0.024 % Ophthalmic Solution [PSN] · latanoprostene bunod 0.24 MG/ML Ophthalmic Solution [SCD] · latanoprostene bunod 0.024 % Ophthalmic Solution [SY]36These highlights do not include all the information needed to use LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION. LATANOPROSTENE BUNOD ophthalmic solution. Initial U.S. Approval: 201720250502